Memorial Sloan Kettering Cancer Center· @MSKCancerCenter · X·· 9 小时前评分45
正文 · 原文
Tomorrow at #ESMO26: MSK gastrointestinal medical oncologist @AndreaCercek will present the first results from the global AZUR1 trial of dostarlimab monotherapy in patients with dMMR/MSI-H locally advanced rectal cancer.
🗓️ Sunday, October 25 | 11:00 a.m. CET
208 浏览 · 5 赞 · 0 转发 · 1 回复
会议摘要
2877RO按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上
Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
https://esmocongress.esmo.org帖内回复
- Vânia Godo@vaniagodo
@MSKCancerCenter @AndreaCercek 👏🏻👏🏻👏🏻👏🏻👏🏻
来源：Memorial Sloan Kettering Cancer Center · x.com